Nothing Special   »   [go: up one dir, main page]

AU5399096A - Combination compositions containing benazepril or benazeprilat and valsartan - Google Patents

Combination compositions containing benazepril or benazeprilat and valsartan

Info

Publication number
AU5399096A
AU5399096A AU53990/96A AU5399096A AU5399096A AU 5399096 A AU5399096 A AU 5399096A AU 53990/96 A AU53990/96 A AU 53990/96A AU 5399096 A AU5399096 A AU 5399096A AU 5399096 A AU5399096 A AU 5399096A
Authority
AU
Australia
Prior art keywords
benazeprilat
valsartan
compositions containing
combination compositions
containing benazepril
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53990/96A
Other languages
English (en)
Inventor
David Saul Cohen
Marc De Gasparo
Randy Lee Webb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU5399096A publication Critical patent/AU5399096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU53990/96A 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan Abandoned AU5399096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07
CH1012/95 1995-04-07
PCT/EP1996/001440 WO1996031234A1 (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan

Publications (1)

Publication Number Publication Date
AU5399096A true AU5399096A (en) 1996-10-23

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53990/96A Abandoned AU5399096A (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan

Country Status (15)

Country Link
EP (1) EP0820302A1 (xx)
JP (1) JPH11503139A (xx)
KR (1) KR19980703647A (xx)
CN (1) CN1181019A (xx)
AU (1) AU5399096A (xx)
BR (1) BR9604818A (xx)
CA (1) CA2214143A1 (xx)
CZ (1) CZ313897A3 (xx)
HU (1) HUP9801593A2 (xx)
MX (1) MX9707683A (xx)
NO (1) NO974400D0 (xx)
PL (1) PL322529A1 (xx)
SK (1) SK133897A3 (xx)
TR (1) TR199701121T1 (xx)
WO (1) WO1996031234A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002032A1 (en) * 1995-06-30 1997-01-23 Merck & Co., Inc. Method of treating renal disease using an ace inhibitor and an aii antagonist
CN101011390A (zh) 1999-01-26 2007-08-08 诺瓦提斯公司 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
WO2001076573A2 (en) * 2000-04-12 2001-10-18 Novartis Ag Combination of at least two compounds selected from an at1-receptor antagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups
HU229280B1 (en) * 2000-07-19 2013-10-28 Novartis Ag Valsartan salts
EP1671632A1 (en) * 2000-08-22 2006-06-21 Boehringer Ingelheim Pharma GmbH & Co. KG Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
CN1461218A (zh) * 2000-12-18 2003-12-10 诺瓦提斯公司 阿洛地平和贝那普利的治疗组合
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN1465712A (zh) * 2002-07-05 2004-01-07 安徽省生物医学研究所 一种预测acei类降压药药效的试剂盒、方法、软件和复方药
AU2003268219B2 (en) * 2002-08-28 2009-09-24 Barnes-Jewish Hospital Conjoint administration of morphogens and ACE inhibitors in treatment of chronic renal failure
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (zh) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 降压药物组合物
WO2010133638A1 (de) 2009-05-20 2010-11-25 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische telmisartan-trinklösung
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
JP2017504649A (ja) * 2014-01-31 2017-02-09 ヤンセン ファーマシューティカ エヌ．ベー． 腎障害及び脂肪性肝障害の治療並びに予防のための方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU653724B2 (en) * 1990-05-11 1994-10-13 Pfizer Inc. Synergistic therapeutic compositions and methods
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
KR19980703647A (ko) 1998-12-05
NO974400L (no) 1997-09-23
NO974400D0 (no) 1997-09-23
EP0820302A1 (en) 1998-01-28
HUP9801593A2 (hu) 1999-01-28
SK133897A3 (en) 1998-02-04
JPH11503139A (ja) 1999-03-23
TR199701121T1 (xx) 1998-03-21
CZ313897A3 (cs) 1998-01-14
CA2214143A1 (en) 1996-10-10
BR9604818A (pt) 1998-06-09
CN1181019A (zh) 1998-05-06
WO1996031234A1 (en) 1996-10-10
PL322529A1 (en) 1998-02-02
MX9707683A (es) 1997-12-31

Similar Documents

Publication Publication Date Title
AU6374896A (en) Cable-sheathing composition
AU5060796A (en) Composition
AU4266596A (en) Composition and use
PL322571A1 (en) Deodoising composition
GB9518033D0 (en) Composition
AU5399096A (en) Combination compositions containing benazepril or benazeprilat and valsartan
HU9600352D0 (en) Bitumenous composition
AU6747798A (en) Hexanitrohexaazaisowurtzitane composition and explosive composition containing said composition
HUP9802997A3 (en) Antisudorific and/or deodorant compositions
AU1609497A (en) Bactericidal compositions and articles containing them
AU1081897A (en) Heterocyclic compounds and their use
AU1129697A (en) Modified polyalkadiene-containing compositions
AU5774796A (en) Pharmaceutical compositions containing lornoxicam and cyclod extrin
AU3421297A (en) Composition containing thiocarbonates and acylated-nitrogen containing compounds
GB9508323D0 (en) Composition
AU1468797A (en) Ghrh-rp compositions and methods
ZA963825B (en) Composition of matter
EP0757075A3 (en) Polyaminotriazine composition
AUPN498095A0 (en) Compounds and compositions
AU4090196A (en) Composition
GB9511701D0 (en) Composition
AU1141497A (en) Heterocyclic compounds and their use
AU6622196A (en) Composition and its use
GB9512703D0 (en) Composition and use
GB9526499D0 (en) Primer composition